Related Experiment Video
Updated: Mar 9, 2026

Studying the Hypothalamic Insulin Signal to Peripheral Glucose Intolerance with a Continuous Drug Infusion System into the Mouse Brain
Published on: January 4, 2018
Endogenous α2A-Adrenoceptor-Operated Sympathoadrenergic Tones Attenuate Insulin Secretion via cAMP/TRPM2 Signaling
Kiyonori Ito1, Katsuya Dezaki2, Masashi Yoshida1
1First Department of Integrated Medicine, Saitama Medical Center, Jichi Medical University, Saitama, Japan.
Abstract:
In pancreatic β-cells, pharmacological concentrations of catecholamines, including adrenaline, have been used to inhibit insulin release and explore the multiple mechanisms involved. However, the significance of these signaling pathways for physiological adrenergic functions in β-cells is largely unknown. In the process of glucose-induced insulin secretion, opening of background current through nonselective cation channels (NSCCs) might facilitate membrane depolarization by closure of the ATP-sensitive K+ channels. Here, we examined whether physiological insulinostatic adrenaline action is mediated via the transient receptor potential melastatin 2 (TRPM2) channel, a type of NSCC, in β-cells. Results showed that physiological concentrations of adrenaline strongly suppressed glucose-induced and incretin-potentiated cAMP production and insulin secretion and inhibited NSCCs current and membrane excitability via the α2A-adrenoceptor in wild-type mice; however, insulin secretion was not attenuated in TRPM2-knockout (KO) mice. Administration of yohimbine, an α2-adrenoceptor antagonist, failed to affect glucose tolerance in TRPM2-KO mice, in contrast to an improved glucose tolerance in wild-type mice receiving the antagonist. The current study demonstrated that a physiological concentration of adrenaline attenuates insulin release via coupling of α2A-adrenoceptor to cAMP/TRPM2 signaling, thereby providing a potential therapeutic tool to treat patients with type 2 diabetes.
Insights
Physiological adrenaline suppresses insulin release by activating α2A-adrenoceptors and TRPM2 channels in pancreatic beta cells. This pathway offers a potential therapeutic target for type 2 diabetes treatment.
Area of Science:
- Endocrinology
- Cell Physiology
- Molecular Pharmacology
Background:
- Adrenaline's role in physiological insulin regulation by pancreatic beta cells is poorly understood.
- Nonselective cation channels (NSCCs) are implicated in glucose-induced insulin secretion.
- Transient Receptor Potential Melastatin 2 (TRPM2) is a type of NSCC found in beta cells.
Purpose of the Study:
- To investigate if physiological adrenaline action in beta cells is mediated by the TRPM2 channel.
- To elucidate the signaling pathway linking adrenergic stimulation to insulin secretion inhibition.
Main Methods:
- Electrophysiological recordings of NSCCs current in beta cells.
- Measurement of cAMP production and insulin secretion in response to glucose and incretins.
- Experiments using wild-type and TRPM2-knockout mice.
- Assessment of glucose tolerance in vivo.
Main Results:
- Physiological adrenaline suppressed glucose- and incretin-stimulated insulin secretion and cAMP production in wild-type mice.
- Adrenaline inhibited NSCCs current and reduced beta cell membrane excitability via α2A-adrenoceptors.
- TRPM2-knockout mice showed no suppression of insulin secretion by adrenaline.
- α2A-adrenoceptor antagonist yohimbine improved glucose tolerance in wild-type but not TRPM2-knockout mice.
Conclusions:
- Physiological adrenaline inhibits insulin release through a pathway involving α2A-adrenoceptor, cAMP, and TRPM2 channels in pancreatic beta cells.
- This signaling axis represents a potential therapeutic target for managing type 2 diabetes.
More Related Videos
Related Concept Videos
cAMP-dependent Protein Kinase Pathways
Glucose Homeostasis: Pancreatic Islets and Insulin Secretion
Insulin and C-peptide are...
Adrenergic Receptors: β Subtype
Isoprenaline > Adrenaline > Noradrenaline
Neurotransmitter binding to these receptors causes activation of adenylyl cyclase resulting in increased concentrations of cAMP and modulation of calcium ion channels within the cell. They are further classified into β1, β2, and β3 subtypes.
β1-adrenoceptors: β1-adrenoceptors...
Insulin: The Receptor and Signaling Pathways
Adrenergic Receptors: ɑ Subtype
Adrenaline ≥ Noradrenaline >> Isoprenaline
α-adrenoceptors are further divided into α1 and α2-adrenoceptors.
α1-Adrenoceptors: These receptors are located postsynaptically on the effector organs and cause constriction of smooth muscle mediated by activation of phospholipase...
GPCRs Regulate Adenylyl Cylase Activity

